Dr. Mouabbi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-798-1910
Education & Training
Ascension St John HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020- Ascension St John HospitalResidency, Internal Medicine, 2014 - 2017
St. George's University School of MedicineClass of 2014
Certifications & Licensure
FL State Medical License 2021 - Present
MI State Medical License 2017 - 2028
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) Start of enrollment: 2024 Oct 31
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 37 citationsInvasive lobular carcinoma: an understudied emergent subtype of breast cancer.Jason A Mouabbi, Amy Hassan, Bora Lim, Gabriel N Hortobagyi, Debasish Tripathy
Breast Cancer Research and Treatment. 2022-06-01 - 34 citationsSummary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-F-Fluoro-17β-Fluoroestradiol.Gary A Ulaner, David A Mankoff, Amy S Clark, Amy M Fowler, Hannah M Linden
Journal of Nuclear Medicine. 2023-03-01 - 6 citationsHistology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett Jr, Amy Hassan, Debu Tripathy
NPJ Breast Cancer. 2022-12-20
Authored Content
- Navigating the Horizon: Anticipating Breakthroughs at SABCS 2023November 2023
Press Mentions
A Guide to Breast Cancer ScreeningOctober 28th, 2024- Six Significant Studies in HR+ Disease From SABCS 2022December 19th, 2022
- Highlights from the San Antonio Breast Cancer Symposium with Jason Mouabbi, MDDecember 11th, 2022
- Join now to see all
External Links
- MD Anderson Profilehttps://faculty.mdanderson.org/profiles/jason_mouabbi.html
- Lobular Breast Cancer Alliancehttps://lobularbreastcancer.org/lbca-welcomes-dr-jason-mouabbi-to-scientific-advisory-board/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
